Serial 90426944
Live / Registered — Registered (as of 07 Jan 2025)
What this means for you
Registered since 07 Jan 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90426944
- Registration number
- 7644695
- Mark type
- Design / logo
- Filed
- 29 Dec 2020
- Published for opposition
- 20 Jul 2021
- Registered
- 07 Jan 2025
- Attorney of record
- Yana Gorbach
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine diseases and disorders, namely, human growth hormones
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 30 Jan 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 07 Jan 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jan 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Dec 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 18 Dec 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 07 Oct 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Aug 2024 — USE AMENDMENT FILED
- 20 Aug 2024 — TEAS STATEMENT OF USE RECEIVED
- 09 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2024 — SOU EXTENSION 5 GRANTED
- 26 Jan 2024 — SOU EXTENSION 5 FILED
- 08 Feb 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Jan 2024 — SOU TEAS EXTENSION RECEIVED